News stories about Phibro Animal Health Corporation (NASDAQ:PAHC) have been trending somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Phibro Animal Health Corporation earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.0050951652265 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

Phibro Animal Health Corporation (NASDAQ PAHC) remained flat at $37.40 during trading on Wednesday. 75,296 shares of the stock traded hands. The stock’s 50 day moving average is $38.56 and its 200 day moving average is $33.09. Phibro Animal Health Corporation has a 12-month low of $20.14 and a 12-month high of $40.25. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of 23.23 and a beta of 1.35.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be issued a dividend of $0.10 per share. The ex-dividend date is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.07%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is 24.69%.

A number of brokerages recently commented on PAHC. Piper Jaffray Companies set a $35.00 price objective on Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. BidaskClub lowered Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Bank of America Corporation reiterated an “underperform” rating and issued a $33.00 price objective on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Zacks Investment Research upgraded Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a research report on Thursday, May 11th. Finally, Credit Suisse Group lowered Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price objective for the stock from $29.00 to $36.00 in a research report on Friday, June 2nd. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $31.86.

ILLEGAL ACTIVITY NOTICE: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/phibro-animal-health-corporation-pahc-given-daily-media-sentiment-score-of-0-08/1532373.html.

In other Phibro Animal Health Corporation news, VP Daniel M. Bendheim sold 1,443 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $40.05, for a total transaction of $57,792.15. Following the transaction, the vice president now owns 300 shares in the company, valued at approximately $12,015. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Bfi Co., Llc sold 48,000 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.82, for a total value of $1,671,360.00. Following the transaction, the insider now owns 96,000 shares in the company, valued at approximately $3,342,720. The disclosure for this sale can be found here. Insiders have sold a total of 268,657 shares of company stock worth $9,802,503 in the last quarter. Company insiders own 48.09% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.